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Abstract 24 
The aim of this study was to investigate if a pre-exercise alkalosis mediated attenuation of HSP72 had 25 
any effect on the response of the same stress protein after a subsequent exercise. Seven physically active 26 
males (25.0 ± 6.5 years, 182.1 ± 6.0 cm, 74.0 ± 8.3 kg, peak aerobic power (PPO) 316 ± 46 W) performed 27 
a repeated sprint exercise (EXB1) following a dose of 0.3 g kg-1 body mass of sodium bicarbonate 28 
(BICARB), or a placebo of 0.045 g kg-1 body mass of sodium chloride (PLAC). Participants then 29 
completed a 90-min intermittent cycling protocol (EXB2). Monocyte expressed HSP72 was significantly 30 
attenuated after EXB1 in BICARB compared to PLAC, however there was no difference in the HSP72 31 
response to the subsequent EXB2 between conditions. Furthermore there was no difference between 32 
conditions for measures of oxidative stress (protein carbonyl and HSP32). These findings confirm the 33 
sensitivity of the HSP72 response to exercise induced changes in acid-base status in vivo, but suggest 34 
that the attenuated response has little effect upon subsequent stress in the same day. 35 
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Introduction 53 
Exposure to an extracellular acidosis has been demonstrated to increase HSP72 gene activity in monkey 54 
kidney cells (pH = 6.8) (Gapen and Moseley, 1995) and the expression of HSP72 protein in cultured rat 55 
astrocytes (pH = 5.2) (Narasimhan et al., 1996), with a potential mechanism being the initiation of protein 56 
degradation via the ATP dependent ubiquitin proteasome pathway (Mitch et al. 1994, Price et al. 57 
1994). However, these in vitro models are difficult to apply to the whole organism due to the extreme 58 
pH limits employed. Recent research in human studies inducing a pre-exercise alkalosis using sodium 59 
bicarbonate (NaHCO3) has demonstrated an attenuation of the stress protein following high-intensity 60 
anaerobic exercise (Peart et al. 2011, 2013a), but not following a longer sub-maximal 90-min cycling 61 
effort (Peart et al. 2013b). These findings therefore suggest that HSP72 is also sensitive to less extreme 62 
shifts in acid-base balance in vivo (pH = 7.15). However it was not investigated in this previous work 63 
whether the attenuated response of HSP72 would have any implications for the stress response from a 64 
subsequent exercise.  65 
 66 
One of the primary purposes of HSP72 is to facilitate cross-tolerance to a subsequent stressor, and 67 
Madden et al. (2008) proposed that its expression could enhance cellular tolerance to the stress of 68 
exercise. Moreover authors have shown that increases in monocyte expressed HSP72 in particular can 69 
provide protection to oxidative stress in a subsequent exercise (Taylor et al, 2012). In light of this it is 70 
possible that attenuating the acute exercise induced HSP72 response to exercise via NaHCO3 may inhibit 71 
this particular mechanism of defence to a second bout of exercise.  72 
 73 
The aim of this study was to confirm previously published data and further expand whether this would 74 
have any implications for the subsequent HSP72 response and oxidative stress response to a second 75 
exercise in the same day. 76 
  77 
Materials and Methods 78 
Participants 79 
Seven recreationally active non-smoking males (mean ± SD; age 25.0 ± 6.5 years, height 182.1 ± 6.0 80 
cm, body mass 74.0 ± 8.3 kg, absolute peak power output (PPO) 316 ± 46 W and relative PPO 4.3 ± 1.0 81 
W.kg-1) volunteered for the study. All participants provided written informed consent in accordance with 82 
the departmental and University ethical procedures and following the principles outlined in the 83 
Declaration of Helsinki. None of the participants were supplementing their diet with any ergogenic aids 84 
prior to testing. Participants were instructed not to exercise in the 24-h prior to testing, and to also abstain 85 
from foods and beverages high in alcohol, fat and caffeine (Sandstrom et al., 2009, Taylor et al., 2010a) 86 
  87 
Exercise protocols 88 
Prior to the experimental trials all participants performed a ramped PPO test on a cycle ergometer (Lode 89 
Sport Excalibur, Netherlands). The test started with a 5-min warm up at 50 W, and workload increased 90 
thereafter by 30 W.min-1 until volitional exhaustion. The PPO from this test was used to prescribe an 91 
individual workload for both exercise bouts (EXB1 and EXB2 respectively). EXB1 was a high-intensity 92 
anaerobic exercise consisting of 10 x 15-s sprints against 120% PPO separated by 45-s active recovery 93 
and EXB2 was a 90-min interval cycling exercise (10 x 9-min blocks of exercise consisting of 306 s at 94 
40 % PPO, 204 s at 60 % PPO, 8 s at 0 W, 14 s sprint at 120 % PPO and 8 s at 0 W). Both protocols have 95 
been described in full in Peart et al (2013a) and Peart et al (2013b) respectively. 96 
  97 
 Experimental Design 98 
Participants reported to the laboratory on three occasions, with the first visit consisting of the described 99 
PPO test followed by a familiarisation to the testing procedures. Visits two and three were the 100 
experimental trials completed in a blinded and randomised manner. These trials began with ingestion of 101 
either 0.3 g.kg.BW-1 NaHCO3 (BICARB) or an equimolar (sodium) dose of sodium chloride (NaCl - 102 
0.045g.kg.BW-1) placebo (PLAC), followed by a 60-min rest period. The NaHCO3 and NaCl were 103 
ingested in gelatine capsules as opposed to in a liquid solution as per previous research (Artioli et al 104 
2007, Flinn et al 2014, Peart et al 2013b) as the capsules may facilitate participant blinding by removing 105 
the taste (Peart et al, 2012) and offer a more preferable mode of consumption (Carr et al, 2011). All of 106 
the gelatine capsules were opaque so participants could unknowingly ingest empty capsules to allow a 107 
matched number of capsules per condition. 108 
    109 
A venous blood sample was taken 60-min post-ingestion, after which participants performed EXB1. 110 
After 90-min rest (determined from the peak HSP72 response observed in Peart et al., (2013b)) 111 
participants began EXB2. A venous blood sample was taken immediately post EXB2, and a final venous 112 
blood sample was taken 60-min post EXB2. Fig 1 provides a visual representation of the experimental 113 
trials. Capillary blood samples for the measurement of acid-base variables (pH, HCO3-, base excess and 114 
lactate) were taken immediately before and 60-min after ingestion of the pills (both pre-exercise), 115 
immediately post EXB1 and prior to EXB2. All capillary blood samples were collected in 100 µl 116 
balanced heparin blood gas capillary tubes and analysed immediately (Radiometer, ABL800, 117 
Copenhagen, Denmark). Venous blood samples for the measurement of HSP72 were drawn from the 118 
antecubital vein into potassium EDTA Vacuette tubes (Vacuette®, Greiner BIO-one, UK) at the time 119 
points already described.  120 
 121 
Oxidative stress was quantified by the measurement of protein carbonyl using a commercially available 122 
assay kit (Cayman, UK). The expression of HSP72 and HSP32 were measured via flow cytometry in 123 
monocytes using a well-established assay method (Sandstrom et al. 2009, Vince et al., 2010 Peart et al 124 
2013b, Taylor et al, 2012). Whole blood (100 µl) was transferred from the potassium EDTA tubes into 125 
2 ml of red blood cell lysis buffer (diluted 1/10 with distilled water; Erythrolyse, AbD Serotec, UK) and 126 
left to incubate for 10 minutes. Following incubation, samples were centrifuged for 5-min at 3000 rpm 127 
to pellet the white blood cells, and the resultant supernatant discarded. White blood cells were 128 
subsequently washed in 2 ml phosphate buffering solution (PBS) and centrifuged for 5-min at 3000 rpm, 129 
with the supernatant discarded. Following a second wash 100µl of Fix solution (Leucoperm Reagent A, 130 
AbD Serotec) was added to the samples and left to incubate for 15-min. After incubation, samples were 131 
washed as above and permeabilised by the addition of 100 µl of Perm solution (Leucoperm Reagent B, 132 
AbD Serotec). Each sample was then divided into two 50 µl aliquots. Added to these aliquots were 4 µl 133 
of either anti-HSP72:FITC (IgG1) / anti-HSP32:FITC (IgG2B) (Enzo Life Sciences, USA) or an isotype 134 
matched negative control:FITC (AbD Serotec). Following 30 min incubation in the dark, samples were 135 
washed with PBS and then re-suspended in 300 µl PBS ready for flow cytometry. Samples were analysed 136 
by flow cytometry on a BDFACSCalibur® (BD Biosciences, UK) running CELLQuest Software (BD 137 
Biosciences, UK), with monocytes and lymphocytes gated by forward scatter (FSC; cell size) and side 138 
scatter (SSC; cell granularity) properties, with a total of 20,000 events counted. Results were calculated 139 
as the ratio of mean fluorescence intensity (MFI) gained with the anti-HSP antibody to that obtained with 140 
the isotype matched negative control. 141 
 Statistical Analysis 142 
All statistical analyses were completed using IBM SPSS Statistics 18 (SPSS Inc. Chicago, IL). Central 143 
tendency and dispersion of the sample data are represented as the mean ± SD. The change in acid-base 144 
variables and biochemical variables across condition and time were analysed using linear mixed models. 145 
The expression of HSP72 and HSP32 were expressed as the ratio of the mean fluorescence intensity 146 
(MFI) gained from the anti-HSP72/anti-HSP32 antibody to that obtained with the isotype matched 147 
negative control. Post hoc tests with Sidak-adjusted p values were used to locate significant paired 148 
differences, with two-tailed statistical significance accepted at p < 0.05. 149 
  150 
Results 151 
The NaHCO3 ingestion protocol significantly elevated blood pH, HCO3- and base excess at rest. EXB1 152 
significantly altered all acid-base variables in PLAC, with pH, HCO3-, and base excess all maintained 153 
closer to pre-exercise values in BICARB (Table 1). 154 
  155 
HSP72 was significantly higher post EXB1 in PLAC compared to BICARB (Fig 2) (33 vs. 8% increase 156 
respectively; F = 4.588, p = 0.050), (Fig 1) a result apparent in all participants (Fig 3). The HSP72 157 
response following EXB2 was similar in both conditions (F = 2.633, p = 0.115), with a significant main 158 
effect for time (F = 13.484, p < 0.001) whereby HSP72 significantly increased 60-min post exercise (p 159 
< 0.001) (Fig 2). HSP32 was unchanged following EXB1 (less than 10% change in both trials), but was 160 
significantly higher (F = 11.085, p < 0.001) 60-min post EXB2 compared to rest and pre EXB2 (p < 161 
0.001) regardless of condition (Fig 4). Furthermore HSP32 was significantly higher immediately post 162 
EXB2 compared with immediately before (p = 0.018) regardless of condition. The concentration of 163 
protein carbonyl did not change significantly from rest throughout the testing period (F = 1.920 p = 164 
0.174), and was comparable between conditions (F = 1.476, p = 0.249) (Table 2). 165 
  166 
Discussion 167 
The efficacy of the supplementation protocol was demonstrated by the observation of a significantly 168 
altered blood acid-base balance prior to EXB1 (Table 1), and a significantly attenuated HSP72 response 169 
post EXB1 in the BICARB trial as per previous research (Peart et al, 2013a). A lower basal level of 170 
HSP72 prior to EXB2 in BICARB though did not affect the magnitude of the response following the 90-171 
min protocol of EXB2. Hypoxia is another stimulus that can result in ubiquitin- proteasome mediated 172 
protein degradation, via induction by hypoxia-inducible factor (HIF) (Brahimi-Horn and Pouysségur, 173 
2005). Taylor et al (2012) reported a significantly attenuated HSP72 response post-exercise (~50%) after 174 
basal HSP72 expression was elevated via a hypoxic exposure, therefore it could have been expected that 175 
the trial with the lower basal HSP72 (BICARB) prior to EXB2 would have resulted in increased HSP72 176 
expression following the bout. However it must be noted that the average changes in basal levels between 177 
experimental conditions in the research from Taylor et al (2012) was higher than in the present study 178 
(67% and 31% respectively). Therefore it may be the case that the HSP72 response to EXB1 in this study 179 
was not of a high enough magnitude to influence the response to EXB2. 180 
 181 
As other authors have shown that increasing the level of HSP72 prior to exercise can improve defences 182 
to the oxidative damage associated with exercise (Taylor et al., 2012), both HSP32 and protein carbonyl 183 
were measured prior to and after EXB2. Monocyte HSP32 was induced after EXB2 to the same extent 184 
in both conditions. This is in contrast to the HSP32 response to the same 90-min exercise bout in previous 185 
research, which was attenuated under BICARB conditions (Peart et al. 2013b). In the current study acid-186 
base values had returned to homeostasis prior to EXB2 resulting in comparable acid-base results between 187 
conditions (Table 1), whereas in the previous study blood pH, base excess and HCO3 were significantly 188 
different between conditions prior to and throughout the exercise. This finding supports our previous 189 
suggestions that increased oxidative damage is not necessarily the only stimulus for increased HSP32 190 
and that this particular HSP is highly sensitive to acid-base changes in vivo (Peart et al. 2013b) as well 191 
as in vitro (Christou et al, 2004). 192 
  193 
The protein carbonyl data adds further support for the notion that oxidative stress is not the sole stimulus 194 
for increases in HSP32. Protein carbonyl was measured in this study as a second marker more specific 195 
to protein oxidative damage after HSP32 was significantly attenuated in the previous research (Peart et 196 
al. 2013b). Although quantification of this marker of protein oxidative damage has previously produced 197 
conflicting responses following anaerobic exercise (Alessio et al., 2000, Bloomer et al., 2006, 198 
Bloomer et al., 2007b, Bloomer et al., 2005), it has been widely reported to increase following exercise 199 
typically aerobic in nature. Such exercises include cycling interventions lasting 15 to 120-min (Alessio et 200 
al., 2000, Bloomer et al., 2007a, Michailidis et al., 2007), a half marathon race (Sureda et al., 2013) and 201 
ultra-distance cycling (Tauler et al., 2003) and running (Radak et al., 2000). Despite this trend seen in 202 
previous research, protein carbonyl did not increase at any time point throughout the testing period in 203 
this study nor was any difference observed between conditions. The only other study reporting no 204 
increase in protein carbonyl following aerobic exercise utilised a 90-min cycling protocol at 70% of 205 
maximum (Morillas-Ruiz et al., 2005). Fisher-Wellman and Bloomer (2009) have suggested that studies 206 
reporting null findings for protein carbonyl may be due to insufficient sampling times, exercise protocols 207 
that are too short or physical training status of the participants. Additionally, some authors have reported 208 
peaks in protein carbonyl occurring around 4-6 hours post-exercise (Bloomer et al., 2005, Michailidis et 209 
al., 2007), therefore it is possible that sample timings in this study may have contributed to no observed 210 
increases in protein carbonyl, as the final blood sample was 60-min post EXB2, and Morillas-Ruiz et al, 211 
(2005) only took a sample 20-min post exercise. However, other authors have demonstrated peaks in 212 
protein carbonyl immediately post-exercise of a similar duration to the current study (Bloomer 2007a, 213 
Sureda et al, 2013). Finally the training status is unlikely to have resulted in the absence of an increased 214 
protein carbonyl from rest in this study as the participants were less physically active compared with 215 
other studies, and lesser trained individuals have been shown to have greater protein carbonyl responses 216 
following exercise (Tauler et al., 2003). In the current study participants cycled predominantly at 40-217 
60% of maximum during EXB2, whereas Bloomer et al, (2007a) used an intensity of 70% and 218 
Michailidis et al, (2007) 70-90% maximum suggesting the  current protocol may not have been a high 219 
enough stimulus to elicit increases in protein carbonyl. However Morillas-Ruiz et al, (2005) also applied 220 
an intensity of 70% with null findings. Furthermore increases in oxygen consumption are unlikely to be 221 
the sole cause of protein carbonyl increases following exercise as authors have at times demonstrated 222 
increases in protein carbonyl following exercises of relatively low  demands compared to sub-maximal 223 
exercise (Alessio et al., 2000, Bloomer et al., 2005). In summary we witnessed no increase in protein 224 
carbonyl concentration following either exercise bout, which is in contrast to previous work using similar 225 
exercise modalities/duration. The reason for this is unclear as this study also had similar sampling times 226 
following exercise to other studies, a factor which has been suggested to contribute to null findings 227 
(Fisher-Wellman and Bloomer, 2009).  228 
  229 
The increase in HSP72 after EXB1 observed in this study is less than the results reported in previous 230 
research (~30% and ~80% respectively) (Peart et al, 2013a). So as acknowledged earlier in the 231 
discussion, the magnitude of the response may have been inadequate to influence HSP72 expression 232 
following EXB2, and it is unclear whether an increase similar to the original study would have had more 233 
effect upon the subsequent response. This draws attention to whether documenting the stress response 234 
on a single day of training is necessarily fully reflective of the role of HSP72 in sport and exercise and 235 
future investigations should document intra-individual variance in the response to acute exercise. Other 236 
authors have shown that protein damage can progressively increase over several days training, as can the 237 
intracellular HSP72 response to exercise (Whitham et al., 2004). Therefore future work may also 238 
consider further examining the effect of pre-exercise mediated alterations in the response of HSP72 by 239 
documenting the implications of manipulating the HSP72 stress response over a longer period training, 240 
and any subsequent effect upon exercise performance and recovery times. This would allow further 241 
insight into whether chronic attenuation of HSP72 would have additional implications during a 242 
presumably more stressful period, and may inform future work investigating the hormetic nature of 243 
oxidative stress for training adaptation (Powers et al, 2010). From a practical viewpoint these findings 244 
suggest that individuals choosing to ingest NaHCO3 acutely for its possible ergogenic effect (Peart et al. 245 
2012) do not risk interfering with the physiological stress response to a subsequent exercise in the same 246 
day. 247 
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Fig 1  Schematic of the experimental trials 380 
 381 
Fig 2 Mean ± SD Monocyte expressed HSP72 pre and post EXB1 and EXB2 during the PLAC and 382 
BICARB trials. * significantly different to BICARB (p = 0.05), † significantly different to pre EXB2 383 
(p  <0.001), ‡ significantly different to 0-min post EXB2 (p < 0.001).   384 
 385 
Fig 3 Individual changes in monocyte expressed HSP72 after EXB1, expressed as percentage change 386 
from rest 387 
 388 
Fig 4 Mean ± SD Monocyte expressed HSP32 during the PLAC and BICARB trials. * significantly 389 
different to pre EXB1 and pre EXB2 (p  ≤ 0.041). 390 
  391 
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 393 
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 398 
 399 
 400 
 401 
 402 
 403 
 404 
 405 
 406 
 407 
 408 
 409 
Table 1 Acid-base characteristics pre- and post-NaHCO3 ingestion, immediately post EXB1 
and pre EXB2 (means ± SD) 
  
    Pre-ingestion Post-
ingestion 
Post EXB1 Pre EXB2 
pH PLAC 7.40 ± 0.01 7.40 ± 0.02 7.19 ± 0.04† 7.39 ± 0.02 
  BICARB 7.39 ± 0.01 7.44 ± 0.02*‡ 7.27 ± 0.05†‡ 7.40 ± 0.02 
HCO3- (mmol/L) PLAC 24.56 ± 0.70 23.02 ± 3.49 14.85 ± 4.35† 24.22 ± 1.19 
  BICARB 24.28 ± 1.15 27.5 ± 0.97*‡ 15.45 ± 2.21† 25.9 ± 1.53 
Base excess 
(mEq/L) 
PLAC 0.35 ± 1.37 0.30 ± 1.00 -13.93 ± 2.05† 0.43 ± 1.21 
  BICARB 0.44 ± 1.21 3.84 ± 1.18*‡ -10.82 ± 3.09†‡ 2.47 ± 1.49‡ 
Lactate (mmol/L) PLAC 1.40 ± 0.47 1.38 ± 0.28 13.65 ± 1.09† 2.16 ± 0.38† 
  BICARB 1.28 ± 1.66 1.65 ± 0.23 14.30 ± 1.89† 2.50 ± 0.48† 
*significantly different to pre-ingestion (p<0.05), †significantly different to post-ingestion (p<0.05), 
‡significantly different to PLAC (p<0.05) 
 410 
Table 2 Protein carbonyl (nmol/ml) during the PLAC and BICARB trials (means ± SD) 
  
    Pre EXB1 90-min post 
EXB1 / Pre 
EXB2 
0-min post 
EXB2 
60-min post 
EXB2 
Protein carbonyl  PLAC 44.18 ± 8.07 42.23 ± 5.02 40.55 ± 5.55 36.73 ± 11.45 
  BICARB 48.69 ± 12.27 49.18 ± 8.32 38.16 ± 12.04 46.05 ± 13.54 
 411 
